Major predictive risk factors for а cytokine storm in COVID-19 patients (a retrospective clinical trials)
Автор: Anisenkova Anna Y., Apalko Svetlana V., Asaulenko Zakhar P., Bogdanov Alexander N., Vologzhanin Dmitry A., Garbuzov Evgenii Y., Glotov Oleg S., Kamilova Tatyana A., Klitsenko Olga A., Minina Evdokiia M., Mosenko Sergei V., Khobotnikov Dmitry N., Sсherbak Sergey G.
Журнал: Клиническая практика @clinpractice
Рубрика: Оригинальные исследования
Статья в выпуске: 1 т.12, 2021 года.
Бесплатный доступ
Background: According to WHO, as of March 31, 2021, 127 877 462 confirmed cases of the new COVID-19 coronavirus infection were registered in the world, including 2 796 561 deaths (WHO Coronavirus Disease). COVID-19 is characterized by a wide range of clinical manifestations, from asymptomatic to a rapid progression to severe and extremely severe. Predictive biomarkers for the early detection of high-risk individuals have become a matter of great medical urgency. Aims: Search for the predictors of a cytokine storm in patients with COVID-19 infection and creation of a risk scale of this complication for practical applications. Methods: The study included 458 patients with confirmed COVID-19 infection with signs of viral lung lesions according to the computer tomography data. The patients were divided into 2 groups: those with a stable course of moderate severity (100 patients) and those with progressive moderate, severe and extremely severe course (358 patients). Results: It has been established that the main risk factors for the development of a cytokine storm in COVID-19 patients are the following: interleukin-6 concentration >23 pg/ ml, dynamics of the index on the NEWS scale ≥0, ferritin concentration >485 ng/ml, D-dimer concentration >2.1, C-reactive protein concentration >50 mg/l, number of lymphocytes in the blood function show_eabstract() { $('#eabstract1').hide(); $('#eabstract2').show(); $('#eabstract_expand').hide(); }
COVID-19 infection, cytokine storm, early diagnosis and monitoring
Короткий адрес: https://sciup.org/143175838
IDR: 143175838 | DOI: 10.17816/clinpract63552